Hemoglobin subunit gamma 1 promoter CCAAT box (HBG1 promoter CCAAT box)

The Hemoglobin subunit gamma 1 (HBG1) promoter CCAAT box is a vital cis-regulatory element located within the promoter of the gene encoding the gamma-globin subunit of fetal hemoglobin (HbF) [nih.gov, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411354/]. There are typically two such motifs: a distal CCAAT box at approximately -115 bp and a proximal one at -85 bp relative to the transcription start site [nih.gov, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137534/]. These elements are primarily bound by the activator Nuclear Factor Y (NF-Y), which is essential for high-level expression of fetal hemoglobin during gestation [nih.gov, https://pubmed.ncbi.nlm.nih.gov/27718361/]. In adult erythroid cells, the repressor BCL11A binds to a motif that overlaps with the distal CCAAT box, sterically hindering NF-Y binding and leading to the silencing of gamma-globin in favor of adult beta-globin [nih.gov, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137534/]. Naturally occurring mutations in this region are associated with Hereditary Persistence of Fetal Hemoglobin (HPFH), a condition that mitigates the severity of sickle cell disease and beta-thalassemia [researchgate.net, https://www.researchgate.net/publication/311534845]. Modern therapeutic strategies utilize gene editing tools like CRISPR-Cas12a and base editors to disrupt the repressor binding site or mimic HPFH mutations, thereby reactivating HbF production as a curative treatment for hemoglobinopathies [transfusionnews.com, https://transfusionnews.com/2024/04/28/gene-editing-of-hbg1-and-hbg2-promotors-to-treat-beta-thalassemia-and-sickle-cell-disease/]. Clinical trials for agents like renizgamglogene autogedtemcel have demonstrated the efficacy of targeting this element in increasing HbF levels and reducing vaso-occlusive events [aabb.org, https://www.aabb.org/news-resources/news/article/2024/04/15/investigational-gene-editing-therapy-shows-promise-for-sickle-cell-disease-and-beta-thalassemia].

Other names

HBG1 CCAAT motifGamma-globin promoter CCAAT box-115 CCAAT boxDistal CCAAT boxProximal CCAAT boxHBG1 promoter -115 region

Disruption of transcriptional repressor binding (e.g., BCL11A) or enhancement of activator recruitment (e.g., NF-Y) to induce fetal hemoglobin (HbF) expression [nih.gov, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137534/].